SYS-CON MEDIA Authors: Kevin Benedict, Adrian Bridgwater, Carmen Gonzalez, Dana Gardner, Elizabeth White

News Feed Item

Cardiac Arrest Global Clinical Trials Review, H1, 2014

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Cardiac Arrest Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiac Arrest. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cardiac Arrest 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cardiac Arrest 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Cardiac Arrest 33
Nov 07, 2012: Metformin Offers Cardio Benefits Over Sulfonylureas In Diabetes, Study Finds 33
Aug 22, 2012: NIH Launches Trial To Evaluate Anti-inflammatory Treatment For Preventing Heart Attacks, Strokes, And Cardiovascular Deaths 33
Aug 22, 2012: Brigham And Women's Hospital Researchers Initiate Major Cardiovascular Inflammation Reduction Trial Using Teva's Trexall 34
Mar 25, 2012: Infusion Of Abciximab Into Coronary Artery May Reduce Size Of Heart Damage After Heart Attack 35
Nov 13, 2011: Anti-Clotting Drug Lowers Risks In Acute Coronary Syndrome Treatment 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Janssen Global Services, LLC 37
Clinical Trial Overview of Janssen Global Services, LLC 37
Boston Scientific Corporation 38
Clinical Trial Overview of Boston Scientific Corporation 38
Biotronik SE & Co. KG 39
Clinical Trial Overview of Biotronik SE & Co. KG 39
PT Dexa Medica 40
Clinical Trial Overview of PT Dexa Medica 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Janssen-Cilag A.G. 42
Clinical Trial Overview of Janssen-Cilag A.G. 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of Top Institutes / Government 44
Ottawa Hospital Research Institute 44
Clinical Trial Overview of Ottawa Hospital Research Institute 44
University of Washington 45
Clinical Trial Overview of University of Washington 45
National Heart, Lung, and Blood Institute 46
Clinical Trial Overview of National Heart, Lung, and Blood Institute 46
Kyoto University 47
Clinical Trial Overview of Kyoto University 47
Medical University of Vienna 48
Clinical Trial Overview of Medical University of Vienna 48
University of Pennsylvania 49
Clinical Trial Overview of University of Pennsylvania 49
Sunnybrook Health Sciences Centre 50
Clinical Trial Overview of Sunnybrook Health Sciences Centre 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
University Hospital Basel 52
Clinical Trial Overview of University Hospital Basel 52
National Taiwan University Hospital 53
Clinical Trial Overview of National Taiwan University Hospital 53
Five Key Clinical Profiles 54
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Cardiac Arrest Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 37
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 38
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik SE & Co. KG, 2014* 39
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by PT Dexa Medica, 2014* 40
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 41
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 42
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 44
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 45
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 46
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 47
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 48
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 49
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2014* 50
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 51
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 52
Cardiac Arrest Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 53

List of Figures

Cardiac Arrest Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cardiac Arrest Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 76

To order this report: Cardiac Arrest Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p0869179/Cardiac-Arrest-Global-Clinical-Trials-Review-H1-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
@ThingsExpo has been named the Top 5 Most Influential M2M Brand by Onalytica in the ‘Machine to Machine: Top 100 Influencers and Brands.' Onalytica analyzed the online debate on M2M by looking at over 85,000 tweets to provide the most influential individuals and brands that drive the discussion. According to Onalytica the "analysis showed a very engaged community with a lot of interactive tweets. The M2M discussion seems to be more fragmented and driven by some of the major brands present in the...
DevOps Summit, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developmen...
SYS-CON Events announced today that B2Cloud, a provider of enterprise resource planning software, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. B2cloud develops the software you need. They have the ideal tools to help you work with your clients. B2Cloud’s main solutions include AGIS – ERP, CLOHC, AGIS – Invoice, and IZUM
As cloud gives an opportunity to businesses to buy services externally – how is cloud impacting your customers? In his General Session at 15th Cloud Expo, Fabio Gori, Director of Worldwide Cloud Marketing at Cisco, provided answers to big questions: Do you see hybrid cloud as where the world is going? What benefits does it bring? And how does Cisco connect all of these clouds? He also discussed Intercloud and Cisco’s investment on it.
Database apps on mobile devices shouldn't stop working when there's limited or no network connectivity. In his session at 16th Cloud Expo, Bradley Holt, a Developer Advocate for IBM Cloudant, will discuss how to bring data stored in a cloud database to the edge of the network (and back again), whenever an Internet connection is available. He will demonstrate techniques for replicating cloud databases with mobile devices in order to build offline-enabled mobile apps that can provide a better,...
The WebRTC Summit 2015 New York, to be held June 9-11, 2015, at the Javits Center in New York, NY, announces that its Call for Papers is open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 16th International Cloud Expo, @ThingsExpo, Big Data Expo, and DevOps Summit.
It's time to put the "Thing" back in IoT. Whether it’s drones, robots, self-driving cars, ... There are multiple incredible examples of the power of IoT nowadays that are shadowed by announcements of yet another twist on statistics, databases, .... Sorry, I meant, Big Data(TM), tiered storage(TM), complex systems(TM), smart nations(TM), .... In his session at WebRTC Summit, Dr Alex Gouaillard, CTO and Co-Founder of Temasys, will discuss the concrete, cool, examples of IoT already happening tod...
There is no doubt that Big Data is here and getting bigger every day. Building a Big Data infrastructure today is no easy task. There are an enormous number of choices for database engines and technologies. To make things even more challenging, requirements are getting more sophisticated, and the standard paradigm of supporting historical analytics queries is often just one facet of what is needed. As Big Data growth continues, organizations are demanding real-time access to data, allowing immed...
Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 16th Cloud Expo at the Javits Center in New York June 9-11 will find fresh new content in a new track called PaaS | Containers & Microservices Containers are not being considered for the first time by the cloud community, but a current era of re-consideration has pushed them to the top of the cloud agenda. With the launch ...
The world's leading Cloud event, Cloud Expo has launched Microservices Journal on the SYS-CON.com portal, featuring over 19,000 original articles, news stories, features, and blog entries. DevOps Journal is focused on this critical enterprise IT topic in the world of cloud computing. Microservices Journal offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. Follow new article posts on T...
SYS-CON Events announced today Isomorphic Software, the global leader in high-end, web-based business applications, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Isomorphic Software is the global leader in high-end, web-based business applications. We develop, market, and support the SmartClient & Smart GWT HTML5/Ajax platform, combining the productivity and performance of traditional desktop software ...
SYS-CON Events announced today that CenturyLink, Inc., a leader in the network services market, has been named “Platinum Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. CenturyLink is the third largest telecommunications company in the United States and is recognized as a leader in the network services market by technology industry analyst firms. The company is a global leader in cloud infrastructure and ...
SYS-CON Events announced today that MangoApps will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY., and the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. MangoApps provides private all-in-one social intranets allowing workers to securely collaborate from anywhere in the world and from any device. Social, mobile, and eas...
WebRTC defines no default signaling protocol, causing fragmentation between WebRTC silos. SIP and XMPP provide possibilities, but come with considerable complexity and are not designed for use in a web environment. In his session at @ThingsExpo, Matthew Hodgson, technical co-founder of the Matrix.org, discussed how Matrix is a new non-profit Open Source Project that defines both a new HTTP-based standard for VoIP & IM signaling and provides reference implementations.
The security devil is always in the details of the attack: the ones you've endured, the ones you prepare yourself to fend off, and the ones that, you fear, will catch you completely unaware and defenseless. The Internet of Things (IoT) is nothing if not an endless proliferation of details. It's the vision of a world in which continuous Internet connectivity and addressability is embedded into a growing range of human artifacts, into the natural world, and even into our smartphones, appliances, a...